A non-hormonal oral medication (brand Veozah) FDA-approved for menopausal hot flashes.
Also known as: Veozah
Fezolinetant, sold as Veozah, is a non-hormonal oral medication that targets a brain pathway (the neurokinin 3 receptor) involved in temperature regulation. The FDA approved it for moderate-to-severe hot flashes due to menopause.
It provides a non-estrogen option; a prescriber evaluates suitability and monitors as directed by the label.